Fee pressures and general negative sentiment about the state of the current fundraising market are the major obstacles weighing on private equity GPs attempting to bring in new capital, the latest research from law firm Dechert shows.
Truelink Capital, the Los Angeles buyout house launched by a pair of former Platinum Equity managing directors three years ago, is already back in the market with its sophomore fundraise.
A&M Capital, the private equity investment arm of consulting business Alvarez & Marsal, is reportedly raising up to $500m for its debut secondaries fund.
Nexus Venture Partners, which targets cross-border growth opportunities between India and the US, has collected another $700m through the final close of its eighth flagship fund.
Bridgepoint has reinvested in Brevo, a European specialist in email marketing software, as part of the company’s latest €500m financing round - giving the company unicorn status.
Specialist private equity house WindRose Health Investors has pulled in $2.6bn at the final close of its seventh flagship fund, almost double the size of its predecessor vehicle.